论文部分内容阅读
乙型肝炎病毒 ( HBV)持续感染是导致乙型肝炎慢性化、肝硬化和原发性肝癌的重要因素。干扰素( TFN)是目前公认的治疗慢性 HBV感染的有效药物之一 ,但因其有效适应证少 ,远期有效率低和有一定的不良反应 ,而无法成为治疗 HBV感染的主要药物。新一代核苷类似物拉米夫定 ( 3TC)治?
Persistent infection with Hepatitis B virus (HBV) is an important factor leading to chronic hepatitis B, cirrhosis and primary liver cancer. Interferon (TFN) is currently recognized as one of the effective drugs for the treatment of chronic HBV infection, but it can not become the main drug for the treatment of HBV infection due to its low effective indication, low long-term efficacy and certain adverse reactions. A new generation of nucleoside analogue lamivudine (3TC) treatment?